Coming May 1, 2019
Karl Deisseroth, M.D., Ph.D.
D.H. Chen Professor of Bioengineering and Psychiatry at Stanford, and Investigator of the Howard Hughes Medical Institute
Karl Deisseroth, M.D. Ph.D., is the D.H. Chen Professor of Bioengineering and Psychiatry at Stanford, and Investigator of the Howard Hughes Medical Institute. A neuroscientist and bioengineer, he also completed his psychiatry residency at Stanford, and continues as a board-certified psychiatrist specializing in affective and autism-spectrum disorders. He received his AB from Harvard, MD from Stanford, and PhD from Stanford in 1998.
He launched his lab at Stanford in July 2004, where he and his team created and developed 1) optogenetics with microbial opsin genes, 2) hydrogel-tissue chemistry (which includes methods such as CLARITY), and 3) a broad range of enabling methods. He also launched (and directs) the undergraduate Bioengineering degree program at Stanford.
For his discoveries, Deisseroth has received awards that include the NIH Director’s Pioneer Award (2005), Zuelch Prize (2012), Perl Prize (2012), BRAIN Prize (2013), Pasarow Prize (2013), Breakthrough Prize (2015), BBVA Award (2016), Massry Prize (2016) and Harvey Prize from the Technion in Israel (2017).
Deisseroth was also the sole recipient (for optogenetics) of the 2010 Koetser Prize, 2010 Nakasone Prize, 2013 Lounsbery Prize, 2014 Dickson Prize in Science, 2015 Keio Prize, 2015 Lurie Prize, 2015 Albany Prize, 2015 Dickson Prize in Medicine, 2017 Redelsheimer Prize, 2017 Fresenius Prize, and 2018 Eisenberg Prize.
He was elected to the US National Academy of Medicine in 2010 and National Academy of Sciences in 2012.